MedPath

Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk

Not Applicable
Recruiting
Conditions
Quality of Life
Registration Number
NCT05268783
Lead Sponsor
University Hospital, Antwerp
Brief Summary

Neuroendocrine tumors (NET) are rare tumors that require specific diagnosis and treatment. Therefore, this poses a challenge for clinical practice. Diagnosis and treatment can be optimized when physician specialists and other healthcare providers, across various hospitals, join forces to provide patients the best care. Based on this idea, a hospital network called NETwerk was set up. The following hospitals are part of this network: University Hospital Antwerp, VITAZ, AZ Monica, AZ Voorkempen, AZ Klina, Gasthuiszusters Antwerpen, Ziekenhuis Netwerk Antwerpen and AZ Rivierenland. In this NETwerk, patients with a neuroendocrine tumor or patients suspected with a neuroendocrine tumor are discussed with the specialists and treated.The aim of this study is to map the quality of life of NET patients within NETwerk in order to optimize the quality of care. Throughout the diagnosis, the treatment process and the follow-up, the patient will be asked to fill out three questionnaires (QLQ-C30, QLQ-GI.NET21 and a satisfaction survey). These questionnaires will be filled out every six months at home. Patients will be asked to complete these questionnaires over a period of five years.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • NEN patient
  • 18 years or older
  • Patient should appear in Oncobase
Exclusion Criteria
  • Patients who do not have an email address

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Quality of life measurement with QLQ-GI.NET21 questionnaire5 years

Quality of life measurement with QLQ-GI.NET21 questionnaire

Quality of life measurement with QLQ-C30 questionnaire5 years

Quality of life measurement with QLQ-C30 questionnaire

Secondary Outcome Measures
NameTimeMethod
Quality of care measurement with satisfaction survey5 years

Quality of care measurement with satisfaction survey

Trial Locations

Locations (7)

AZ Klina

🇧🇪

Brasschaat, Antwerp, Belgium

AZ Monica

🇧🇪

Deurne, Antwerp, Belgium

Antwerp University Hospital

🇧🇪

Edegem, Antwerp, Belgium

AZ Rivierenland

🇧🇪

Rumst, Antwerp, Belgium

VITAZ

🇧🇪

Sint-Niklaas, East-Flanders, Belgium

ZNA

🇧🇪

Antwerp, Belgium

GZA

🇧🇪

Antwerp, Belgium

AZ Klina
🇧🇪Brasschaat, Antwerp, Belgium
Wim Demey
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.